| Description | Erzotabart, an IgG1-kappa monoclonal antibody targeting CD38 (ADP-ribosyl cyclase 1, cyclic ADP-ribose hydrolase 1, cADPr hydrolase 1, cADPR1) in Homo sapiens, exhibits antineoplastic activity [1]. |
| molecular weight | N/A |
| CAS | 2430792-01-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |